Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2008
05/22/2008US20080118939 Anti-idiotype antibody for use as calibration tool in detecting anti-drug antibodies
05/22/2008US20080118937 Monoclonal antibody for detecting staphylococcal infection
05/22/2008US20080118936 Polyclonal antibodies against fibrinogen degradation products and associated methods of production and use
05/22/2008US20080118935 Using filamin A concentration as diagnostic indicator of celll proliferative disorders
05/22/2008US20080118929 Using concentration of transcription intermediary factor-1 beta (TIF1-beta) as diagnostic/prognostic indicator oc cell proliferative disorders
05/22/2008US20080118529 Improves immunogenicity of vaccines for cancer, immunocastration, autoimmune diseases, atherosclerosis, amyloidoses, graft-versus-host rejections and transplant rejections
05/22/2008US20080118526 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
05/22/2008US20080118525 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/22/2008US20080118524 Anti-IgE Vaccines
05/22/2008US20080118522 Using lymphocyte receptor specific immunoglobulins to treat and prevent viral infection, asthma, cardiovascular, autoimmune, cell proliferative and inflammatory disorders
05/22/2008US20080118521 Using short intefering nucleotide sequences specific to helix-loop-helix protein (HEY-1) to treat and prevent osteoprosis and bone disorders; gene expression inhibition; antisense agents
05/22/2008US20080118520 Variable heavy chains; immunoglobulins; neurodegenerative diseases
05/22/2008US20080118517 Human monoclonal antibodies against interleukin 8 (IL-8)
05/22/2008US20080118515 Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of Diseases
05/22/2008US20080118514 Using toll-like receptor 4 specific immunoglobulin as therapeutic tool in treatment and prevention of inflammatory bowel, atherosclerotic and arthritic disorders
05/22/2008US20080118513 Treatment of immune disorders with antibodies to costimulating polypeptide of T cells
05/22/2008US20080118512 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
05/22/2008US20080118510 Vegf-related protein
05/22/2008US20080118509 For directly inducing cell death without immune effector cells; antigens
05/22/2008US20080118508 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
05/22/2008US20080118506 Humanized Anti-Factor D Antibodies and Uses Thereof
05/22/2008US20080118505 Reagents and treatment methods for autoimmune diseases
05/22/2008US20080118504 Pattern recogniton receptor for use in identifying modulator for treatment and prevention of sepsis, graft vs host, autoimmune, inflammatory and respiratory disorders
05/22/2008US20080118503 Immunoglobulin specific to leptin receptor/leptin binding protein for use in prevention and treatment of eating, arthritic and autoimmune disorders
05/22/2008US20080118502 Using metalloproteinase modulators as stimulatory tools in tissue regeneration; tissue engineering
05/22/2008US20080118501 Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use
05/22/2008US20080118498 Appetite hormone specific immunoglobulin for prevention and treatment of eating and weight related disorders
05/22/2008US20080118497 Using presence of single nucleotide polymorphism in transient receptor potential channel gene(TRPC) as diagnostic/prognostic tool in detecting idiopathic pulmonary arterial hypertension (IPAH)
05/22/2008US20080118493 Elevated Hedgehog Pathway Activity In Digestive System Tumors, And Methods Of Treating Digestive Sytem Tumors Having Elevated Hedgehog Pathway Activity
05/22/2008US20080118487 Cell growth factor polypeptide for use in enhancing muscle growth and treatment muscular disorders
05/22/2008US20080118466 Treatment of rheumatoid arthritis with soluble fas-ligand cross-linkers
05/22/2008US20080118438 Loss of function mutations in calcium channel polypeptides associated with sudden cardiac death
05/22/2008US20080118432 Predetermined reference range indicates cancer therapy effectiveness; immunoassay; cancer stem cells bound with labeled antibodies specific for cell surface markers prior to detection in flow cytometer; blood, bone marrow, serum, urine, interstitial fluid; breast, brain cancer, acute lymphoid leukemia
05/22/2008CA2670259A1 Compounds, compositions and methods for controlling invertebrate pests
05/22/2008CA2669891A1 Expression system of nell peptide
05/22/2008CA2669800A1 Nerve elongation promoter and elongation inhibitor
05/22/2008CA2669237A1 Enterococcus faecalis and/or enterococcus faecium antigens
05/22/2008CA2669181A1 Lingo binding molecules and pharmaceutical use thereof
05/22/2008CA2668714A1 Methods of treating, diagnosing or detecting cancer
05/22/2008CA2668693A1 Therapeutic uses of tim-3 modulators
05/22/2008CA2668496A1 Cancerous disease modifying antibodies
05/22/2008CA2668484A1 Cancerous disease modifying antibodies 180706-02
05/22/2008CA2665239A1 Human antibodies that bind cxcr4 and uses thereof
05/22/2008CA2663012A1 Elisa for vegf
05/22/2008CA2654000A1 Anti-dll4 antibodies and methods using same
05/22/2008CA2652728A1 Antibodies to sars coronavirus
05/22/2008CA2646611A1 Combinatorial therapy
05/21/2008EP1923465A1 Inhibitor protein for the WNT signal pathway
05/21/2008EP1923463A1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hal-a2-positive patient and pharmaceutical comprising the antigen
05/21/2008EP1923402A1 Method for determination of enzymatic activity
05/21/2008EP1923399A1 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
05/21/2008EP1923072A1 Prophylactic/therapeutic agent for cancer
05/21/2008EP1923071A1 Equine herpesvirus vaccine
05/21/2008EP1922416A2 Antigens for vaccination against and detection of mycoplasma suis
05/21/2008EP1922338A2 Polyclonal antiserum against a universal tumor antigen
05/21/2008EP1922337A2 Trail receptor 2 polypeptides and antibodies
05/21/2008EP1752163A4 Agent for actively restoring structure and functions of damaged tissues and organs
05/21/2008EP1682578B1 Peptide-based immunization therapy for treatment of atherosclerosis
05/21/2008EP1668161A4 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways
05/21/2008EP1482981B1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/21/2008EP1454141B1 Method for detecting allergies and use of an antibody to detect allergies
05/21/2008EP1319069B1 Compositions and methods for the therapy and diagnosis of lung cancer
05/21/2008EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods
05/21/2008EP1161262B1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
05/21/2008EP1150714B1 Methods for inhibiting brain tumor growth
05/21/2008EP1097173B1 The use of peptides of il-2 and derivatives thereof as therapeutic agents
05/21/2008EP1064005B1 Urokinase plasminogen activator receptor as a target for diagnosis of micrometastases
05/21/2008EP1054687B1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
05/21/2008EP1007688B1 Desaturase antigen of mycobacterium tuberculosis
05/21/2008EP1004315B1 Preventives and/or remedies containing anti-il-6 receptor neutralizing antibodies for reducing the excretion of urinary protein in systemic lupus erythematosus
05/21/2008EP1003545B1 Heparin-binding growth factor (hbgf) polypeptides
05/21/2008EP0850304B1 Cerebellum-derived growth factors, and uses related thereto
05/21/2008CN101184997A Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
05/21/2008CN101184778A P-cadherin antibodies
05/21/2008CN101184777A Antibody neutralizers of human granulocyte macrophage colony stimulating factor
05/21/2008CN101184776A Novel anti-plgf antibody
05/21/2008CN101184507A Treatment of inflammatory bowel disease (ibd)
05/21/2008CN101184506A Methods and compositions for modulating hyperstabilized c-met
05/21/2008CN101184502A Polypeptides
05/21/2008CN101182359A Human indoleamine 2,3-dioxygenase polyclonal antibody as well as preparation method and uses thereof
05/21/2008CN101182356A Clenbuterol complete antigen and method for preparing monoclonal antibody thereof
05/21/2008CN101182350A Micrococcus pyogenes alpha-hemolysin and coded sequence thereof
05/21/2008CN100389127C I (mycobacterium tuberculosis) superoxide dismutase
05/20/2008US7375206 Brother of the regulator of imprinted sites (BORIS)
05/20/2008US7375196 PRO19814 antibodies
05/20/2008US7375195 Vectors with DNA encoding pro polypeptides
05/20/2008US7375194 For therapy of Huntington's disease
05/20/2008US7375193 Anti-VEGF antibodies
05/20/2008US7375192 inhibit proliferation of CK-B4 expression; used to diagnose, treat, prevent cancer, to inhibit the progression or metastasis of myeloproliferative and other disorders such as leukemia, T-cell lymphoma, and/or B-cell lymphoma
05/20/2008US7375179 PRO19680 polypeptides
05/20/2008US7375117 Polypeptides
05/20/2008US7375079 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
05/20/2008US7374936 Generation of therapeutic radioconjugate; load isotope onto binding support, elute long lived isotopes, join isotope to targeting particle, recover radioconjugate
05/20/2008US7374911 Cytokine polypeptide for use in diagnosis, prevention and treatment of immunological and/or inflammatory disorders
05/20/2008US7374910 agonist; a memory function improving agent, appetite regulator; an uterine, renal, testis, spleen, heart, prostatic or skeletal muscle function improving agent; antiobesity agent, antiabetic
05/20/2008US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector
05/20/2008US7374888 Detecting anti-bacillus antibody in biological samples; biological and chemical warfare agents
05/20/2008US7374876 Anti-idiotypic antibody and its use in diagnosis and therapy of Hepatitis C Virus related diseases
05/20/2008US7374763 Foot-and-Mouth Disease virus (FMDV), or their epitopes; vaccine from the grafting of peptide epitopes derived from FMDV into swine antibody CDR loops, FMDV peptide epitopes are cloned by polymerace chain reaction PCR from VP1 gene of FMDV
05/20/2008US7374761 Antigen-binding fragment (immunoglobulin) which bind to epitope of tumor necrosis factor (TNF) and inhibits its activity; diagnosis and treatment